Antigen-specific T cells CART/CTL and DCvac

BIOLOGICAL2 trials

Sponsors

Shenzhen Geno-Immune Medical Institute

Conditions

B-Cell Acute Lymphoblastic LeukemiaCancer

Phase 1

Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis

TerminatedNCT04085159

Shenzhen Geno-Immune Medical InstituteCancer

Start: 2026-06-01End: 2026-07-31Updated: 2026-08-24

NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

TerminatedNCT05262673

Shenzhen Geno-Immune Medical InstituteB-Cell Acute Lymphoblastic Leukemia

Start: 2026-06-01End: 2026-07-31Updated: 2026-08-24